Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice

Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice

Obeticholic acid (OCA) improves cholestasis and is generally well tolerated in patients with primary biliary cholangitis (PBC) not responding, or intolerant, to ursodeoxycholic acid (UDCA). As PBC is mainly a cholestatic disorder, less attention is paid to aminotransferase behavior in the course of...

Full description

Bibliographic Details
Main Authors: Sara Labanca, Valentina Cacciato, Paolo Borro, Simona Marenco, Giulia Pieri, Antonino Picciotto, Maria Corina Plaz Torres, Edoardo G. Giannini
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Immuno
Subjects:
treatment
outcome
alanine aminotransferase
alkaline phosphatase
real-life
Online Access:https://www.mdpi.com/2673-5601/1/4/33

Internet

https://www.mdpi.com/2673-5601/1/4/33

Similar Items